Enanta Pharmaceuticals (ENTA) Operating Income Growth (3y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.96% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -29.67% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -50.81% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.47% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -12.10% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 55.96% |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | 33.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.03% |
| Dec 31, 2025 | 27.89% |
| Sep 30, 2025 | 12.07% |
| Jun 30, 2025 | 16.58% |
| Mar 31, 2025 | 10.18% |
| Dec 31, 2024 | 8.18% |
| Sep 30, 2024 | 3.98% |
| Jun 30, 2024 | 10.60% |
| Mar 31, 2024 | -3.33% |
| Dec 31, 2023 | -41.56% |
| Sep 30, 2023 | -16.19% |
| Jun 30, 2023 | -17.12% |
| Mar 31, 2023 | -49.21% |
| Dec 31, 2022 | -63.01% |
| Sep 30, 2022 | -83.77% |
| Jun 30, 2022 | -120.12% |
| Mar 31, 2022 | -196.08% |
| Dec 31, 2021 | -45.68% |
| Sep 30, 2021 | -43.89% |
| Jun 30, 2021 | -51.76% |
| Mar 31, 2021 | -55.52% |
| Dec 31, 2020 | -41.87% |
| Sep 30, 2020 | -33.22% |
| Jun 30, 2020 | -20.29% |
| Mar 31, 2020 | -7.70% |
| Dec 31, 2019 | 56.41% |
| Sep 30, 2019 | 59.73% |
| Jun 30, 2019 | 75.96% |
| Mar 31, 2019 | -32.15% |
| Dec 31, 2018 | -7.85% |
| Sep 30, 2018 | 110.87% |
| Jun 30, 2018 | 136.89% |
| Mar 31, 2018 | -29.72% |
| Dec 31, 2017 | -41.06% |
| Sep 30, 2017 | 130.17% |
| Jun 30, 2017 | -33.44% |
| Mar 31, 2017 | -22.85% |
| Dec 31, 2016 | -8.89% |
| Sep 30, 2016 | 12.97% |
| Jun 30, 2016 | 36.12% |
| Mar 31, 2016 | 47.93% |
| Dec 31, 2015 | 17.56% |
| Sep 30, 2015 | 42.55% |
| Jun 30, 2015 | 35.41% |
| Mar 31, 2015 | 14.80% |